SCHEMBL7148319

SCHEMBL7148319

Clc1ccc(-c2nc(CCNc3ccccc3)ncc2-n2ccnc2)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.50
CDK1 P06493 1/20 0.50
GSK3A P49840 1/20 0.50
CNR1 P21554 3/20 0.41
CNR2 P34972 1/20 0.41
PDE5A O76074 4/20 0.40
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
IDO1 P14902 2/20 0.38
CD38 P28907 2/20 0.38
FBP1 P09467 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
IDH1 O75874 1/20 0.36
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5089665 0.82 CDK1 (0.51) GSK3BCDK1GSK3ACNR1CNR2
SCHEMBL7148326 0.80 CDK1 (0.41) GSK3BCDK1GSK3ACNR1CNR2
SCHEMBL5089661 0.76 GSK3B (0.60) GSK3BCDK1GSK3ACNR1CNR2
SCHEMBL27253612 0.75 CDK1 (0.49) GSK3BCDK1GSK3ACNR1CNR2
SCHEMBL27538053 0.75 GSK3B (0.56) GSK3BCDK1GSK3ACNR1CNR2
SCHEMBL23780644 0.72 GSK3B (0.69) GSK3BCDK1GSK3ACNR1CNR2
SCHEMBL27559817 0.72 IDO1 (0.55) GSK3BCDK1GSK3ACNR1CNR2
SCHEMBL5099510 0.71 CNR1 (0.51) GSK3BCDK1GSK3ACNR1CNR2
SCHEMBL29367195 0.71 IDO1 (0.50) GSK3BCDK1GSK3ACNR1CNR2
Hydrochloric Acid SCHEMBL18813498 0.71 GSK3B (0.68) GSK3BCDK1GSK3ACNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1317433-A2 INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 CHIRON CORPORATION (US) 2003-06-11 EP disclosed
WO-2002020495-A2 INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 CHIRON CORPORATION (US) 2002-03-14 WO disclosed